1. Home
  2. AUID vs ALXO Comparison

AUID vs ALXO Comparison

Compare AUID & ALXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUID
  • ALXO
  • Stock Information
  • Founded
  • AUID 2009
  • ALXO 2015
  • Country
  • AUID United States
  • ALXO United States
  • Employees
  • AUID N/A
  • ALXO N/A
  • Industry
  • AUID Computer Software: Prepackaged Software
  • ALXO Biotechnology: Pharmaceutical Preparations
  • Sector
  • AUID Technology
  • ALXO Health Care
  • Exchange
  • AUID Nasdaq
  • ALXO Nasdaq
  • Market Cap
  • AUID 88.5M
  • ALXO 76.5M
  • IPO Year
  • AUID N/A
  • ALXO 2020
  • Fundamental
  • Price
  • AUID $7.03
  • ALXO $1.62
  • Analyst Decision
  • AUID
  • ALXO Buy
  • Analyst Count
  • AUID 0
  • ALXO 6
  • Target Price
  • AUID N/A
  • ALXO $11.00
  • AVG Volume (30 Days)
  • AUID 41.9K
  • ALXO 1.4M
  • Earning Date
  • AUID 11-07-2024
  • ALXO 11-07-2024
  • Dividend Yield
  • AUID N/A
  • ALXO N/A
  • EPS Growth
  • AUID N/A
  • ALXO N/A
  • EPS
  • AUID N/A
  • ALXO N/A
  • Revenue
  • AUID $758,638.00
  • ALXO N/A
  • Revenue This Year
  • AUID N/A
  • ALXO N/A
  • Revenue Next Year
  • AUID N/A
  • ALXO N/A
  • P/E Ratio
  • AUID N/A
  • ALXO N/A
  • Revenue Growth
  • AUID 97.40
  • ALXO N/A
  • 52 Week Low
  • AUID $4.62
  • ALXO $1.19
  • 52 Week High
  • AUID $13.63
  • ALXO $17.83
  • Technical
  • Relative Strength Index (RSI)
  • AUID 57.74
  • ALXO 52.09
  • Support Level
  • AUID $5.50
  • ALXO $1.47
  • Resistance Level
  • AUID $6.37
  • ALXO $2.05
  • Average True Range (ATR)
  • AUID 0.79
  • ALXO 0.22
  • MACD
  • AUID 0.07
  • ALXO 0.01
  • Stochastic Oscillator
  • AUID 100.00
  • ALXO 33.85

About AUID authID Inc.

AuthID Inc is a company engaged in ensuring cyber-savvy enterprises "Know Who's Behind the Device" for every customer or employee login and transaction. Through its easy-to-integrate, patented, biometric identity platform, authID quickly and accurately verifies a user's identity, eliminating any assumption of who is behind a device and preventing cybercriminals from taking over accounts. authID combines digital onboarding, biometric passwordless authentication and account recovery, with a fast, accurate, user-friendly experience-delivering identity verification.

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Share on Social Networks: